Evidence map›Paper›PMID 37641126›Full record

ArticleHuman genomics2023

An AI-powered patient triage platform for future viral outbreaks using COVID-19 as a disease model.

Georgia Charkoftaki, Reza Aalizadeh, Alvaro Santos-Neto, Wan Ying Tan, Emily A Davidson, Varvara Nikolopoulou, Yewei Wang, Brian Thompson, Tristan Furnary, Ying Chen and 17 more

Open access · goldAbstract read
In one paragraph

Article in Human genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Isotopic Ratio Outlier Analysis (IROA) for Quantitative Analysis.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 9 institutions in 4 countries.

Georgia CharkoftakiDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
Reza AalizadehLaboratory of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Athens, Zografou, 15771, Greece.
Alvaro Santos-NetoSão Carlos Institute of Chemistry, University of São Paulo, São Carlos, SP, 13566-590, Brazil.
Wan Ying TanDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
Emily A DavidsonDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
Varvara NikolopoulouLaboratory of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Athens, Zografou, 15771, Greece.
Yewei WangDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
Brian ThompsonDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
Tristan FurnaryDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
Ying ChenDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
Elsio A WunderDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA.
Andreas CoppiCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.
Wade SchulzCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.
Akiko IwasakiDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Richard W PierceDepartment of Pediatrics , Yale School of Medicine, New Haven, CT, USA.
Charles S Dela CruzSection of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, CT, USA.
Gary V DesirDepartment of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, CT, USA.
Naftali KaminskiSection of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, CT, USA.
Shelli FarhadianDepartment of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA.
Kirill VeselkovDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
Rupak DattaVeterans Affairs Connecticut Healthcare System, CT, West Haven, USA.
Melissa CampbellDepartment of Pediatrics, Division of Pediatric Infectious Diseases, School of Medicine, Duke University, NC, Durham, USA.
Nikolaos S ThomaidisDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
Albert I KoDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA.
Yale IMPACT Study Team
David C ThompsonDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
Vasilis VasiliouDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA. Vasilis.vasiliou@yale.edu.
Yale University · USNational and Kapodistrian University of Athens · GRDuke University · USUniversidade Federal de São Carlos · BRYale New Haven Hospital · USHarvard University · USHoward Hughes Medical Institute · USNorwalk Hospital · USYale New Haven Health System · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Mouse Models for Alcohol Metabolism and Tissue InjuryR24AA022057 · NIAAA · YALE UNIVERSITY · PI VASILIOU, VASILIS · 2013 to 2022
$4.5M
Redox Regulation of O-GlcNAcylation Signaling in the Pathogenesis of Alcoholic Fatty Liver DiseaseR01AA028859 · NIAAA · YALE UNIVERSITY · PI Ying Chen · 2022 to 2026
$1.9M
Mechanisms of Endothelial Cell Dysfunction in Critically Ill ChildrenK08HL136898 · NHLBI · YALE UNIVERSITY · PI PIERCE, RICHARD W · 2019 to 2023
$780k
Identification of Biomarkers and Novel Pathways of Alcoholic Liver Disease by Leveraging Metabolomics, Tissue Imaging Mass Spectrometry, and Integrative Machine LearningR21AA028432 · NIAAA · YALE UNIVERSITY · PI VASILIOU, VASILIS · 2020 to 2021
$680k
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS R01 AA028859NIAAA NIH HHS R21 AA028432NIAAA NIH HHS R24 AA022057
6 · The paper itself

Abstract

Over the last century, outbreaks and pandemics have occurred with disturbing regularity, necessitating advance preparation and large-scale, coordinated response. Here, we developed a machine learning predictive model of disease severity and length of hospitalization for COVID-19, which can be utilized as a platform for future unknown viral outbreaks. We combined untargeted metabolomics on plasma data obtained from COVID-19 patients (n = 111) during hospitalization and healthy controls (n = 342), clinical and comorbidity data (n = 508) to build this patient triage platform, which consists of three parts: (i) the clinical decision tree, which amongst other biomarkers showed that patients with increased eosinophils have worse disease prognosis and can serve as a new potential biomarker with high accuracy (AUC = 0.974), (ii) the estimation of patient hospitalization length with ± 5 days error (R

Indexed as

COVID-19AllantoinDisease OutbreaksHumansMachine LearningTriageAllantoin

Identifiers

PMID37641126
PMCPMC10463861
OpenAlexW4386213472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.